Products

Tokimeki.chat

AI-native

Create, share, and chat with AI characters in any language

tokimeki.chat Entertainment & Media / AI Companions & Character Chat

AI Benchmark
Desktop
Mobile
Monthly visits
21.1K
Up231.4%MoMSep 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
spike
@tokimeki_chat· 8 followers
Launched
5mo ago
2026-06-10 · Est.

Traffic

Last 12 months
Monthly visitsData through Sep 2026
Events4 changes · 1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
X accounts@tokimeki_chat@tokimeki_chat

  • Tokimeki.chat launched on Product HuntLaunch

    Create, share, and chat with AI characters in any language

    Jun 10 · 5mo agoSource

Traffic sources

Sep 2026

Traffic breakdown

Channels

  • Direct73%
  • Organic Search22%
  • Referrals4%
  • Other1%

Countries

  • Japan100%

Search

Domain authority —Domain registered 2025-12-17

KeywordMonthly volume
aiチャット キャラクター520
制限が厳しい aiチャット40
tokimeki.chat20
推しと話せるアプリ ai—
くすぐりaiチャット—

Traffic data: Vaneform

Pricing

Website does not list public plan prices.

Trial: None · Observed 2026-11-13 · Source page

Latest price change · Nov 13: Pricing model changed from freemium to freeView change history

Pages & changes

Tracked since 2026-06-10

Key pages

Weekly snapshots

Changes

  1. Nov 13 · Yesterday

    Pricing model changed from freemium to freePricing

    freemium→free

  2. Nov 13 · Yesterday

    Removed PRO planPlan

    —→—

  3. Nov 13 · Yesterday

    Removed 未登録 planPlan

    —→—

  4. Nov 13 · Yesterday

    Removed 無料登録 planPlan

    —→—

Questions & evidence

How much website traffic does Tokimeki.chat get?
Vaneform estimates 21.1K website visits in 2026-09. Visits can include repeat visits; this estimate does not measure paying customers or revenue.Source

Related products in this category

Entertainment & Media / AI Companions & Character Chat

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.